Every material Form 8-K Parker Hannifin has filed with the SEC since July 10, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Parker-Hannifin Corporation reported record sales of $6.0 billion and increased net income for the fiscal first quarter ended September 30, 2026, alongside the completion of the Filtration Group acquisition. Driven by double-digit organic growth and record order rates pushing backlog to $13.7 billion, management raised full-year fiscal 2027 guidance for sales growth, adjusted margins, EPS, and free cash flow. This performance demonstrates strong demand across all market verticals and positive integration progress for shareholders.
Sales for the quarter ended September 30, 2026, increased 18% to a record $6.0 billion, with organic sales up 11.5%.
Diluted earnings per share reached $6.92, while adjusted EPS rose 23% to a record $8.90.
Order rates increased 13% on a rolling 12-month basis, bringing total backlog to a record $13.7 billion.
Full-year fiscal 2027 guidance was raised for organic sales growth, adjusted segment operating margin, adjusted EPS, and free cash flow.
Parker-Hannifin completed its acquisition of Filtration Group on August 13, 2026, for a cash purchase price of $9.25 billion, subject to a net working capital adjustment. The company borrowed $5.25 billion under a 364-Day delayed draw term loan and $2.50 billion under a Three-Year delayed draw term loan to help pay the purchase price and related fees and expenses.
Cash purchase price of $9.25 billion on a cash-free, debt-free basis, subject to a net working capital adjustment
Merger completed August 13, 2026, under the Merger Agreement signed November 10, 2025
Borrowed $5.25 billion under the 364-Day Credit Facility and $2.50 billion under the Three-Year Credit Facility on August 13, 2026
Credit agreements dated December 10, 2025, with Barclays Bank PLC and KeyBank National Association as administrative agents
Parker Hannifin reported fourth-quarter fiscal 2026 sales of $5.8 billion, up 9.8%, and diluted EPS of $8.54, up 19% from $7.15 a year earlier. The company guided fiscal 2027 EPS to $30.00 to $31.00, excluding pending acquisitions, and raised its adjusted segment operating margin target to 30% by fiscal 2031.
Q4 net income was $1.1 billion, up 18%; adjusted EPS was $9.27, up 21%, which includes an $84 million tariff refund benefit to cost of sales.
Fiscal 2027 guidance: reported sales growth of 5.5% to 8.5% and EPS of $30.00 to $31.00, or $34.25 to $35.25 adjusted.
Adjusted segment operating margin target raised by 300 basis points to 30% by fiscal 2031.
Fiscal 2026 cash flow from operations was $4.4 billion, and the company returned nearly $2 billion to shareholders.
Parker Hannifin reported record fiscal third-quarter sales of $5.5 billion, up 11%, and adjusted EPS of $8.17, up 18%. The company raised its fiscal 2026 outlook, now expecting adjusted EPS of $31.20, and GAAP net income and diluted EPS declined year over year because the prior-year period included a one-time $180 million tax benefit.
Q3 sales rose 11% to a record $5.5 billion, with organic sales up 6.5%.
Diluted EPS was $7.06, down from $7.37 a year earlier, which included a one-time $1.37 discrete tax benefit; adjusted EPS rose 18% to a record $8.17.
Fiscal 2026 guidance: EPS of $27.10 ($31.20 adjusted) and reported sales growth of 7%.
Backlog reached a record $12.5 billion, and the company repurchased $275 million of shares in the quarter.
Parker-Hannifin director Kevin A. Lobo told the company on March 13, 2026, that he will not stand for reelection to the board at the 2026 Annual Meeting of Shareholders. He cited his election to the board of GE HealthCare Technologies Inc. and said the decision was not due to any disagreement with the company over operations, policies or practices. He will remain a director until his current term expires.
Kevin A. Lobo notified the company on March 13, 2026 that he will not stand for reelection
Lobo has served as a Director since 2013
Reason given: election to the board of GE HealthCare Technologies Inc.
Filing states no disagreement with the company on operations, policies or practices
Parker-Hannifin reported fiscal second-quarter results for the quarter ended December 31, 2025, with net sales up 9% to a record $5.2 billion and adjusted EPS up 17% to $7.65. Reported net income fell 11% to $845 million and diluted EPS fell 9% to $6.60, because the year-earlier quarter included a one-time after-tax divestiture gain. The company raised its fiscal 2026 guidance and said it has a definitive agreement to acquire Filtration Group Corporation.
Net sales rose 9% to $5.2 billion, with organic sales up 6.6%
Diluted EPS was $6.60, down from $7.25; adjusted EPS rose 17% to $7.65
Fiscal 2026 EPS guidance raised to $26.26 to $26.86, or $30.40 to $31.00 adjusted
Definitive agreement to acquire Filtration Group Corporation announced; the filing does not state a price
Parker-Hannifin entered into two delayed draw term loan agreements totaling $7.75 billion, a $5.25 billion 364-day facility with Barclays and a $2.50 billion three-year facility with KeyBank. The company says the loans, if drawn, will help finance part of its proposed acquisition of Filtration Group, and it had not borrowed any funds as of December 10, 2025.
364-Day Credit Facility: $5.25 billion, administrative agent Barclays Bank PLC, matures 364 days after funding
Three-Year Credit Facility: $2.50 billion, administrative agent KeyBank National Association, matures three years after initial funding
Proceeds, if drawn, will finance a portion of the proposed Filtration Group acquisition; no borrowings as of December 10, 2025
Loans bear interest at SOFR plus a margin tied to the company's credit rating
Parker-Hannifin agreed on November 10, 2025 to acquire Filtration Group, a private Oakbrook Terrace, Illinois filtration technology company, in a cash deal valued at $9.25 billion on a cash-free, debt-free basis, subject to a working capital adjustment. The purchase price is expected to be financed with new debt and cash on hand, and completion depends on closing conditions including Hart-Scott-Rodino approvals.
Cash purchase price of $9.25 billion, subject to a net working capital adjustment
Expected to be financed with new debt and cash on hand
Closing requires Hart-Scott-Rodino approvals and a preclosing transfer of Filtration Group's Facet Filtration business to its stockholders
Either party may terminate if the merger is not completed by February 10, 2027, subject to extension
Parker-Hannifin reported fiscal first-quarter 2026 sales of $5.1 billion, up 3.7%, and diluted EPS of $6.29, up 18% from a year earlier. The company raised its full-year fiscal 2026 guidance, including the Curtis acquisition, with diluted EPS now expected at $25.53 to $26.33. For shareholders, the filing shows higher profit and a higher profit outlook, though the results include acquisition-related and other adjustments.
Net sales were $5.1 billion ($5,084 million), up 3.7%; organic sales growth was 5%.
Net income was $808 million, up 16%; adjusted EPS was $7.22, up 16%.
FY2026 diluted EPS guidance raised to $25.53 to $26.33 ($29.60 to $30.40 adjusted); sales growth guidance raised to 4.0% to 7.0%.
Segment operating margin was 24.2%, up 160 basis points; Aerospace Systems sales rose 13.3% to $1.6 billion.
On September 1, 2025, Parker-Hannifin's board elected Beth A. Wozniak as a director, effective immediately, with a term running to the October 2025 annual meeting. She also joined the Human Resources and Compensation Committee and the Corporate Governance and Nominating Committee. The filing describes a routine board addition with standard director pay and indemnification terms, and it gives no financial results.
Beth A. Wozniak elected director effective September 1, 2025, term expires at the October 2025 annual meeting
Appointed to the Human Resources and Compensation Committee and the Corporate Governance and Nominating Committee
Eligible for non-employee director compensation, including a pro-rated award of restricted stock units
Indemnification Agreement signed September 1, 2025, substantially the same form as the company's existing director and officer agreement
Parker Hannifin reported fiscal fourth-quarter results for the quarter ended June 30, 2025, with sales of $5.2 billion and diluted EPS of $7.15, up 19% from a year earlier. The company also issued fiscal 2026 guidance calling for sales growth of 2% to 5% and diluted EPS of $24.68 to $25.68, and announced an agreement to acquire Curtis Instruments, Inc.
Q4 net income was $923 million, up 18%; adjusted EPS was a record $7.69, up 14%
Q4 segment operating margin was 23.9%, up 170 basis points; the company repurchased $851 million of shares
Fiscal 2026 guidance: sales growth of 2% to 5% and EPS of $24.68 to $25.68, or $28.40 to $29.40 adjusted
Full-year fiscal 2025 EPS was $27.12, up 24%, and the company repurchased $1.6 billion of shares
Parker Hannifin reported fiscal third-quarter results for the quarter ended March 31, 2025. Net sales were $5.0 billion, down 2.2% from a year earlier, while diluted EPS rose 33% to $7.37, helped by a $179.8 million discrete tax benefit. The company updated fiscal 2025 guidance to sales growth of approximately (1%) and diluted EPS of $25.92 to $26.12, and repurchased $650 million of shares in the quarter.
Net sales of $5.0 billion, down 2.2% as reported; organic sales growth was 1%
Diluted EPS of $7.37 versus $5.56 a year earlier; adjusted EPS of $6.94, up 7%
Quarterly EPS includes a $179.8 million discrete tax benefit, or $1.37 per diluted share
Fiscal 2025 guidance: diluted EPS of $25.92 to $26.12; sales growth of approximately (1%)
Parker Hannifin reported fiscal second-quarter 2025 results for the quarter ended December 31, 2024, with net sales of $4.74 billion, down from $4.82 billion a year earlier, while diluted EPS rose 39% to $7.25 on a reported basis. The company said the reported profit increase was helped by gains on divestitures, and adjusted EPS rose 6% to $6.53. The company also updated its fiscal 2025 guidance, which now calls for sales growth of (2%) to 1% and EPS of $24.46 to $25.06.
Net sales were $4.74 billion versus $4.82 billion a year earlier; organic sales growth was 1%.
Diluted EPS was $7.25 versus $5.23; adjusted EPS was $6.53 versus $6.15, up 6%.
Net income was $949 million, including a $249.7 million gain on divestitures in the quarter.
Fiscal 2025 guidance: sales growth of (2%) to 1% and EPS of $24.46 to $25.06, or $26.40 to $27.00 adjusted.
Parker Hannifin reported fiscal 2025 first-quarter results for the period ended September 30, 2024, with sales of $4.9 billion, up 1.2%, and diluted earnings per share of $5.34, up from $4.99 a year earlier. The company raised its fiscal 2025 EPS outlook to $22.78 to $23.48, reflecting the divestiture of its North America Businesses in the Diversified Industrial segment, which it expects to complete in the second quarter. Diversified Industrial sales fell while Aerospace Systems sales rose 17.8%, so shareholders' results depend on how the two segments perform.
Diluted EPS was $5.34 versus $4.99 a year earlier; adjusted EPS was $6.20, up 4%
Sales were $4.9 billion, up 1.2%, with organic sales growth of 1.4%
Aerospace Systems sales rose 17.8% to $1.45 billion; Diversified Industrial sales fell 4.5% on an as-reported basis
Fiscal 2025 EPS outlook raised to $22.78 to $23.48 and total sales growth guidance set at 0.5% to 3.5%
Parker Hannifin reported fiscal fourth-quarter 2024 sales of $5.2 billion, up 2%, and diluted earnings per share of $6.01, up 10% from a year earlier. It also issued fiscal 2025 guidance calling for total sales growth of 1.5% to 4.5% and EPS of $22.65 to $23.35. Shareholders get a higher quarterly profit and a forecast for the coming year, though the Diversified Industrial segment's sales declined.
Q4 sales rose 2% to $5.2 billion; Aerospace Systems sales rose 19.2% to $1.5 billion, while Diversified Industrial sales fell 4%
Q4 diluted EPS was $6.01, up 10%; adjusted EPS was $6.77, up 11%
Full-year fiscal 2024 diluted EPS was $21.84, up 36%; free cash flow was $2.98 billion
Fiscal 2025 guidance: EPS of $22.65 to $23.35 ($26.30 to $27.00 adjusted) and total sales growth of 1.5% to 4.5%
Parker-Hannifin's board elected E. Jean Savage as a director effective July 10, 2024, with a term running to the October 2024 annual shareholder meeting. She was also named to the Audit Committee and the Corporate Governance and Nominating Committee. The filing describes a routine board addition with no compensation figures disclosed beyond a pro-rated restricted stock unit award she is eligible for.
E. Jean Savage elected as a director effective July 10, 2024, term expires at October 2024 annual meeting
Appointed to the Audit Committee and the Corporate Governance and Nominating Committee
Eligible for pro-rated restricted stock unit award under non-employee director compensation arrangements
Company entered into an indemnification agreement with Ms. Savage on July 10, 2024
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Parker Hannifin filing is on SEC EDGAR ↗. 8-K briefs of other companies →